Related Experiment Video
Updated: Feb 8, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Surgical Closure of the Left Atrial Appendage: The Past, The Present, The Future
John J Squiers1, James R Edgerton1,2
1The Heart Hospital Baylor Plano; Plano, Texas.
Insights
Left atrial appendage (LAA) occlusion can prevent stroke in atrial fibrillation patients. Surgical LAA closure, particularly excision or using devices like AtriClip, is effective for stroke risk reduction.
Area of Science:
- Cardiology
- Vascular Surgery
Background:
- Left atrial appendage (LAA) occlusion is a strategy to prevent stroke in patients with atrial fibrillation.
- Percutaneous LAA closure devices show efficacy, but surgical methods have yielded mixed results.
- Surgical exclusion via sutures or staplers is often ineffective due to LAA recanalization.
Purpose of the Study:
- To assess the efficacy of surgical LAA occlusion for stroke prevention in patients with atrial fibrillation.
- To evaluate the potential benefit of prophylactic LAA closure during cardiac surgery for high-risk patients.
- To investigate LAA occlusion in non-atrial fibrillation surgical patients at risk for developing it post-operatively.
Main Methods:
- Surgical LAA occlusion techniques include excision and specific devices (e.g., AtriClip) for complete closure.
- The Left Atrial Appendage Occlusion Study (LAAOS) III is a large trial assessing surgical LAA occlusion efficacy.
- The ATLAS trial investigates LAA occlusion in surgical patients without atrial fibrillation but at risk.
Main Results:
- Surgical excision and certain devices like AtriClip achieve complete LAA closure.
- Data on routine prophylactic LAA closure during cardiac surgery is currently lacking.
- Ongoing trials (LAAOS III, ATLAS) aim to provide crucial data on LAA occlusion efficacy.
Conclusions:
- Effective surgical LAA occlusion methods exist, offering an alternative for stroke prevention.
- Further research is needed to establish the role of prophylactic LAA closure in cardiac surgery.
- Results from LAAOS III and ATLAS will guide future clinical practice for LAA occlusion in stroke prevention.
Abstract:
Occlusion of the left atrial appendage (LAA) may protect against stroke in patients with atrial fibrillation. While percutaneous LAA closure devices have demonstrated efficacy in stroke reduction, surgical LAA occlusion has been performed with mixed results to date. Although surgical exclusion via internal sutures or noncutting stapler is ineffective due to recanalization of the LAA, surgical excision and certain exclusion devices including the AtriClip device are effective methods to achieve complete closure of the LAA. No data currently exists to support routine, prophylactic LAA closure at the time of cardiac surgery, but this practice may benefit certain patients at high risk for stroke. The currently enrolling Left Atrial Appendage Occlusion Study (LAAOS) III is the largest study to date designed to assess the efficacy of LAA occlusion for stroke prevention. The results of this trial will inform future clinical practice regarding stroke prevention with surgical LAA occlusion for patients with atrial fibrillation. Meanwhile, the ATLAS trial is investigating the efficacy of LAA occlusion in surgical patients who do not have atrial fibrillation but are at increased risk for developing it post-operatively.
Related Concept Videos
Surface Appendages of Archaea
Angle Closure Glaucoma: Treatment
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Cardiac Catheterization III: Left Heart Catheterization
Kidney Transplant II: Surgical Procedure
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:

